The higher P53 level in breast cancer cells restricts the binding of free Keap1 to free Nrf2; therefore, the level of free Nrf2 is higher in the nucleus and induces chemoresistance (Ge et al., 2017). The gene discussed is TP53; the disease is breast carcinoma.